ChinaBio Partnering Forum 2021

May 10 – 14, 2021
Event details
May 10 – 14, 2021
12:00 – 12:00 am China Standard Time

Event summary

ChinaBio Partnering Forum is the largest and most productive life science partnering conference in China where participants will engage with the largest network of potential partners to accelerate their cross-border strategies and expand their reach into the China market. Consisting of two days in-person and 3 days virtual events, this year's hybrid event enables attendees to identify, meet and network with leaders across the life science value chain from global pharma and biotech companies to innovative startups and researchers from leading universities and institutes, as well as VCs and other investors.

As a long-term sponsor, Cooley will continue to host a Partnering Bootcamp Workshop on the first day of the conference with two sessions.

Details and registration

For more information, please email Sandra Sun

Featured agenda items

Monday, May 10, 2021: 14:00 – 15:00 CST

Partnering Bootcamp Session One: Considerations on Forming a Joint Venture

More development stage life sciences JVs are being formed with the goal of eventually going public. We have seen successful examples of such JVs being listed. Should you consider forming JVs? What are the considerations?


  • Christina Zhang – Partner in Charge – Shanghai, Cooley (moderator) 
  • James Li – Co-founder, Chairman and Chief Executive Officer, JW Therapeutics
  • Mai-Jing Liao – Chief Commercial Officer, Harbor BioMed
  • Yiming Liu – Partner, Cooley
  • Blake Salisbury – Senior Vice President of Business Development and Alliance Management, Innovent Biologics

Monday, May 10, 2021: 15:30 – 16:30 CST

Partnering Bootcamp Session Two: The Investors’ Perspectives and Advice on Healthcare IPOs

2021 is gearing up to be another record-breaking year for initial public offerings, as well as private funding rounds, in the healthcare industry. A panel of veteran investors from leading healthcare investment funds will offer their perspectives, and share decades of insights, on healthcare companies’ journeys to their public debut.


  • Yiming Liu – Partner, Cooley (moderator)
  • Fei Chen – Managing Partner, Lilly Asia Ventures
  • Trency Gu – Managing Director, Sequoia Capital
  • Will Liu – Partner, Eight Roads Ventures
  • Lefei Sun – Managing Director, Head of China Healthcare, General Atlantic 

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.